Capmatinib and Abametapir: Interaction Details
- Capmatinib
- Tabrecta
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Capmatinib and Abametapir interaction:
Abametapir
We don't have a drug information page for Abametapir because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Abametapir? Ask a pharmacist, free →
What Happens When You Take Capmatinib With Abametapir
What can happen when they are taken together (rated Major)
Increased exposure of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
For 2 weeks following abametapir application, CYP3A4 substrates should not be used. When this cannot be accomplished, abametapir itself should be avoided.1
The Capmatinib and Abametapir Interaction, Explained
Abametapir is a lotion used on the scalp and hair to treat head lice. After it is applied, it can stay in the body for a while and slow down a liver enzyme (called ) that helps clear capmatinib (Tabrecta), a cancer medicine. If that enzyme is slowed, capmatinib could build up and cause more side effects, such as swelling, nausea, tiredness, or liver problems.
This concern is based on how the drugs work, not on studies in patients. Still, it is taken seriously. Please talk with your pharmacist or doctor before using abametapir. Your care team can help you choose a safe lice treatment.
Mechanism: Abametapir (and its ) inhibits . Capmatinib is a CYP3A4 (also by aldehyde oxidase), so may increase capmatinib exposure (/). Neither agent is activated by CYP3A4, so the expected effect is increased capmatinib exposure.
- Direction: increased capmatinib exposure, with potential for greater toxicity (peripheral edema, nausea, , ILD/pneumonitis, photosensitivity)
- Onset: rapid. may persist after a single topical application.
- Evidence: theoretical. There are no clinical data for this pair, but it carries a major severity rating.
- Management: Avoid CYP3A4 substrates within 2 weeks after abametapir application. If that is not feasible, avoid abametapir and use an alternative pediculicide.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Capmatinib and Abametapir Interact
The likely mechanism
of -mediated by abametapir
How to Manage the Capmatinib and Abametapir Interaction
For this combination, the documented approach is about timing and choosing an alternative:
- Your care team generally avoids using -cleared medicines like capmatinib within 2 weeks after abametapir is applied.
- Because capmatinib is an ongoing cancer treatment, a pause is often not practical. In that case, the usual step is to skip abametapir and pick a different lice treatment.
- Keep taking capmatinib exactly as prescribed. Before treating head lice, tell your pharmacist or oncology team that you take Tabrecta so they can recommend a safe option.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Capmatinib or Abametapir need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Capmatinib and Abametapir: Common Questions
How serious is the Capmatinib and Abametapir interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Capmatinib and Abametapir interaction managed?
For this combination, the documented approach is about timing and choosing an alternative: Your care team generally avoids using -cleared medicines like capmatinib within 2 weeks after abametapir is applied. Because capmatinib is an ongoing cancer treatment, a pause is often not practical. In that case, the usual step is to skip abametapir and pick a different lice treatment. Keep taking cap… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Capmatinib and Abametapir Interaction
Ask in your own words about taking Capmatinib and Abametapir together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: XEGLYZE(TM) topical lotion, abametapir topical lotion. Dr Reddy’s Laboratories Inc (per FDA), Princeton, NJ, 2020. DailyMed
Other Serious Interactions of Capmatinib and Abametapir
Also serious with Abametapir
Also serious with Capmatinib
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Abametapir
- Green TeaModerate
- CannabisModerate
- YohimbeModerate
- Black TeaModerate
- Pu-erh TeaModerate
- AdrafinilModerate
- Cannabidiol (CBD)Moderate
- Cannabinol (CBN)Moderate
- + 14 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.